Prophylactic tetracycline does not diminish the severity of epidermal growth factor receptor (EGFR) inhibitor-induced rash: results from the North Central Cancer Treatment Group (Supplementary N03CB)
Titel:
Prophylactic tetracycline does not diminish the severity of epidermal growth factor receptor (EGFR) inhibitor-induced rash: results from the North Central Cancer Treatment Group (Supplementary N03CB)
Auteur:
Jatoi, Aminah Dakhil, Shaker R. Sloan, Jeff A. Kugler, John W. Rowland, Kendrith M. Schaefer, Paul L. Novotny, Paul J. Wender, Donald B. Gross, Howard M. Loprinzi, Charles L.